J. F. Hermans-van Ast

Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.

A. Zwinderman, Y. Pinto, A. Wilde, 2013, International journal of cardiology.

The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.

D. Atsma, G. Bonsel, Y. Pinto, 2010, European heart journal.

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study

J. De Sutter, R. Tieleman, P. Woudstra, 2021, BMC Geriatrics.

Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriers

Y. Pinto, B. Alzand, S. Schalla, 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest double-heterozygosity?

Y. Pinto, S. Schalla, C. Die-Smulders, 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.

A. Zwinderman, Y. Pinto, E. Arbustini, 2012, Journal of the American College of Cardiology.

Gender‐specific differences in major cardiac events and mortality in lamin A/C mutation carriers

A. Zwinderman, Y. Pinto, E. Arbustini, 2013, European journal of heart failure.